Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality
Natalia M. Sutherland, Baijun Zhou, Lingxiao Zhang, Mei‐Sing Ong, Joseph Hong, Andrew Pak, K Liu, Matthew J. Frigault, Marcela V. Maus, Joshua A. Hill, Kerry L. Reynolds, Jolán E. Walter, Carlos A. Camargo, Sara Barmettler
Topics & Concepts
Chimeric antigen receptorHypogammaglobulinemiaCD19ImmunologyMedicineAntigenVirologyT cellImmune systemAntibodyCAR-T cell therapy researchBiosimilars and Bioanalytical MethodsBiomedical Ethics and Regulation